|
![]() |
|||
|
||||
OverviewCancer is an incredibly diverse and difficult disease to treat, and even after decades of research there is no definitive cure. Therefore, it is highly crucial to search for novel and new organic molecules with high potency, low toxicity, and low mutagenicity with selective anticancer properties that are able to overcome frequently developed resistance to available drugs. Heterocyclic anticancer agents are an important class of drugs for cancer therapies. This book explores different heterocycles and their use as anticancer therapies. Topics covered include different heterocyclic derivatives, the impact of heterocycles on anticancer agent development, and naturally occurring heterocycles. Full Product DetailsAuthor: Bimal Krishna Banik , Bubun BanerjeePublisher: De Gruyter Imprint: De Gruyter Weight: 1.017kg ISBN: 9783110739268ISBN 10: 3110739267 Pages: 532 Publication Date: 21 June 2022 Audience: Professional and scholarly , Professional & Vocational , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: Available To Order ![]() We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately. Table of ContentsReviewsAuthor InformationBimal K. Banik, Prince Mohammad Bin Fahd University, Al-Khobar, Saudi Arabia; Bubun Banerjee, Akal University, India. Tab Content 6Author Website:Countries AvailableAll regions |